Clinical trial

Study of Neurotidine® Intake on Life Quality of Patients With Glaucoma

NCT04046809

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Food for special medical purposes: Neurotidine® Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Neurotidine® Intake on Life Quality of Patients With Glaucoma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-02-13

PhaseNA

Conditions

Glaucomaverified · MONDO: glaucoma

Interventions

Food for special medical purposes: Neurotidine®OTHER

PlaceboOTHER

Sponsors & collaborators

Omikron Italia S.r.l.lead sponsor

Mapped research locations

BarcelonaSpain1 RomaItaly1 LeuvenBelgium1 ThessalonikiGreece1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04046809 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.